Summary A number of reports indicate that protein synthesis is a requirement for the occurrence of apoptosis. In this study, the effect of the protein synthesis inhibitor cycloheximide (CHM) on spontaneous apoptosis of B-chronic lymphocytic leukaemia (B-CLL) cells, previously shown to occur when they are cultured in RPMI-1640 medium with autologous or heterologous serum, was examined. No definite inhibition of apoptosis was observed. Indeed, CHM-treatment augmented apoptosis in the B-CLL cultures and also induced apoptosis of cultured normal peripheral blood lymphocytes. Augmentation was dose-dependent for B-CLL cells over the concentration range 106 M (0.28 yig ml-') to 102 M (2800 yg ml-'), resulting in 9% to 98% apoptosis respectively by 24 h of culture (r = 0.619, P = 0.0008). Normal lymphocytes were affected by CHM over the range 10-4 M to 10-2 M, resulting in 7% to 74% apoptosis respectively (r = 0.794, P = 0.0001). Inhibition of protein synthesis in these cells by CHM was virtually complete at a concentration of 10-3 M. The findings are in accord with some recent reports indicating that suppression of protein synthesis by CHM does not inhibit apoptosis in all circumstances. They also illustrate the marked susceptibility of B-CLL cells, compared with normal lymphocytes, to the induction of apoptosis by this drug. The manner in which CHM triggers apoptosis of some cell types is at present uncertain.
Cell death takes two distinct forms, necrosis and apoptosis, which differ in morphology, biochemistry, incidence and biological significance (reviewed by Wyllie et al., 1980 and Walker et al., 1988) . Whilst necrosis is an outcome of severe injury, apoptosis frequently appears to have a homeostatic or adaptive function (Kerr et al., 1972) . Much recent research on apoptosis has been directed towards elucidating its biochemical mechanisms (reviewed in .
Apoptosis occurring in a number of circumstances has been reported to be abrogated by inhibitors of macro-molecular synthesis such as cycloheximide (CHM), actinomycin D (Act D), puromycin and emetine Wyllie et al., 1984; Yamada & Ohyama, 1988) . Specifically, these circumstances include irradiation of gut crypts (Lieberman et al., 1970) and thymocytes (Sellins & Cohen, 1987; Yamada & Ohyama, 1988) ; exposure of bone marrow cells to cancer-chemotherapeutic agents (Ben-Ishay & Farber, 1975) ; dioxin treatment of thymocytes (McConkey et al., 1988) ; glucocorticoid treatment of B-chronic lymphocytic leukaemia (B-CLL) cells (Galili et al., 1982) , thymocytes and lymphoid cell lines Wyllie et al., 1984) ; regression of the tadpole tail induced by thyroxine (Tata, 1966) ; fusion of the palatal shelf epithelium during normal development (Pratt & Greene, 1976) ; and withdrawal of IL-2 from T-lymphocytes (Bishop et al., 1985) or of fibroblast growth factor from endothelial cells (Araki et al., 1990) .
Suppression of apoptosis by inhibitors of RNA and/or protein synthesis does not, however, appear to be universal. Systems in which an inhibitory effect has been reported to be absent include apoptosis of target cells induced by cytotoxic T lymphocytes (Duke et al., 1983) , apoptosis of activated T cells and macrophages induced by the fungal metabolite gliotoxin (Waring, 1990) , apoptosis of human promyelocytic leukaemia HL-60 cells incuded by calcium ionophore or microtubule-disrupting agents (Martin et al., 1990) , and apoptosis induced in human and murine cell lines by mild hyperthermia (Takano et al., 1991) .
We have previously shown that approximately 20% of unstimulated B-CLL cells spontaneously undergo apoptosis within 30 h when cultured in RPMI-1640 medium with either autologous or heterologous serum (Collins et al., 1989) . In the present study we sought to determine the protein synthetic requirements of the apoptosis in this model using the frequently employed protein synthesis inhibitor CHM.
Materials and methods

Patient selection and cell preparation
Peripheral blood was collected from eight patients diagnosed as having B-CLL by standard clinical and haematological criteria. Mononuclear cells (MNC) were isolated by differential centrifugation (Boyum, 1968) ml-', were added to 25 cm2 culture flasks (Costar, USA) and incubated at 37°C in an atmosphere of 5% CO2 in air. Control and CHM-containing cultures were harvested at 24 h and processed for microscopy as described below. The timecourse of the effects of CHM was assessed in cultures containing 10-', 10-' and 10-3 M CHM harvested at 6, 16, 20 and 24 h; control cultures were also studied at these times.
Microscopy and quantification of cell death Cell death was identified and quantified by light microscopy, the validity of the identification being confirmed by electron microscopy. Cells were washed once in standard phosphatebuffered saline and fixed for 1 h at 4°C in 3% glutaraldehyde (Probing and Structure, Kirwan, Australia) in 0.1 M sodium cacodylate buffer pH 7.3 (BDH Chemicals, Australia) containing 1 M CaCl2 and 0.4 M sucrose. The cells were then resuspended in 1 ml of buffer without glutaraldehyde, postfixed in 1% aqueous osmium tetroxide for 2 h, washed in deionised water, stained en bloc in 5% aqueous uranyl acetate, dehydrated through a series of graded ethanol solutions, cleared in propylene oxide, and embedded in an epon/araldite mixture. Sections cut on an LKB Ultratome V at 1 gim and stained with 1% toluidine blue in 1% aqueous borax solution were used for light microscopy and to select representative areas for electron microscopy. Apoptosis and necrosis were identified by light microscopy using previously defined criteria (Walker et al., 1988 
Phenotype analysis
The phenotype of the patient's cells was typical of B-CLL, the neoplastic cell population comprising monoclonal Blymphocytes, which were immunoglobulin light chain restricted and CDl9-, CD20-, CD5-and MRBC-positive (Table I) .
Identification of the mode of cell death
The light and electron microscopic features of virtually all of the cell death present in both the control and CHM-treated cultures were typical of apoptosis (Walker et al., 1988) . The characteristic condensation and compaction of nuclear chromatin to form circumscribed masses are illustrated in Figure  1 . Only a very occasional necrotic cell was observed; the frequency of necrosis was not influenced by CHM treatment (data not shown).
Effect of increasing molarity of cycloheximide In untreated cultures from the eight patients with B-CLL, the average level of spontaneous apoptosis at 24 h was 10%. No significant diminution in this level of apoptosis was recorded for any of the concentrations of CHM studied. In fact, a significant increase in the extent of apoptosis was recorded for all concentrations of CHM> than 10-5M, with very extensive apoptosis being observed at 10-3 M and 10-2 M (Figure 2) . A dose-dependent correlation existed between the extent of apoptosis and the concentration of CHM over the concentration range 10-6 to 10-2 M (r = 0.619, P = 0.0008).
Compared with the B-CLL cells, normal lymphocytes were less severely affected, with a marked increase in apoptosis occurring at only 10'-and 10-2 M CHM, a dose-dependent correlation being apparent over the range 10-' to 10-2 M (r = 0.794, P = 0.0001) (Figure 2 ). The level of spontaneous apoptosis of normal lymphocytes never exceeded 5% throughout the entire observation period.
Time-course of the response to cycloheximide The time-course of the apoptotic response of B-CLL cells to CHM varied with the concentration; representative data for three patients using 10', 10' and 10-M CHM are shown in Figure 3 . With 10-3 M CHM, a significant increase in apoptosis above the spontaneous levels was apparent by 6 h of culture (P<0.05). With 10-5M CHM, 20h of culture were required to produce an increase showing a similar level of significance (P <0.025).
Electrophoretic analysis of DNA DNA isolated from B-CLL cells cultured for 24 h with concentrations of CHM ranging from 10-' to 10-2 M showed the fragmentation pattern characteristic of apoptosis on electrophoresis (Figure 4) (Wyllie, 1980; Arends et al., 1990) . A comparison with molecular weight markers indicated that the fragments were multiples of approximately 180-200 base pairs, indicating cleavage of chromatin at the internucleosomal region.
DNA from cultures of B-CLL cells treated with the higher concentrations of CHM showed a greater extent of DNA fragmentation and a higher proportion of low molecular weight fragments than did the DNA isolated from cells The mechanisms involved in the induction of apoptosis of B-CLL cells, of normal lymphocytes and of other cell types by CHM (Searle et al., 1975; Martin et al., 1990; Waring, 1990; Takano et al., 1991) are uncertain. As well as inhibiting protein synthesis by blocking peptidyl transferase activity of the 60S ribosomal subunit (Stryer, 1988) , CHM has diverse effects on cell metabolism (discussed in Lee & Dewey, 1986) . Of particular possible relevance in the current context are its ability to inhibit DNA synthesis (Hodge et al., 1969) and to stimulate gene transcription by decreasing the concentration of repressor (Elder et al., 1984; Forsdyke, 1984; Ishihara et al., 1984; Makino et al., 1984) . A number of cytotoxic antibiotics have been shown to bind to chromatin, causing conformational changes in DNA structure (reviewed in Portugal & Waring, 1987) . For example, Act D, frequently used to study the dependence of apoptosis on mRNA and therefore protein synthesis, causes the double helix to partially untwist and become rigid (McGilvery, 1979) . This latter effect may result in exposure of the linker regions between nucleosomes to the activity of endogenous endonuclease, thus producing both the irreversible DNA fragmentation (Paier & Mak, 1974) and apoptosis known to follow exposure of some cell types to Act D (Searle et al., 1975; Martin et al., 1990; Waring, 1990) . It is possible that a similar phenomenon is occurring following treatment with CHM. The direct effects of CHM on DNA clearly merit study. There are, nevertheless, alternative possibilities. It has been suggested by some that certain cells are programmed to undergo apoptosis in the absence of suppressor proteins, which are required to be continually synthesised to maintain cell viability (Martin et al., 1990; Waring, 1990) . It has also been argued teleologically that DNA damage by genotoxic agents may activate a cellular self-destruct mechanism in the interest of the animal as a whole Cohen et al., 1985; Sellins & Cohen, 1987) .
The cause of the gross difference betwen B-CLL cells and normal lymphocytes with respect to the concentration of CHM required to enhance apoptosis is unknown, but may be of relevance to tumour chemotherapy. Such variation in susceptibility of different cell types to the apoptosis-inducing effects of CHM may account for the failure of some authors to observe enhancement of apoptosis by this drug in the past. It is noteworthy that, in the report of inhibition by CHM of apoptosis of cultured endothelial cells induced by withdrawal of fibroblast growth factor referred to in the introduction, high concentrations of CHM were said to be 'cytotoxic' (Araki et al., 1990) . Our results emphasise that caution is needed in drawing conclusions about a requirement for protein synthesis in apoptosis from experiments using a restricted range of concentrations of CHM. Possible multiple effects of the drug need to be considered.
